Tenax Therapeutics Inc. – Filings and Transcripts

NASDAQ: TENX
Share price (7/7/26): $17.38
Market cap (7/7/26): $461 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement

Shelf registration

Registration of securities for employees

Ownership Filter

Price T Rowe Associates Inc

Millennium Management LLC

Dellora Investments LP

Venrock Healthcare Capital Partners III, L.P.

Rtw Investments, LP

News Filter

Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Material Definitive Agreement, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Other Events, Financial Statements or Exhibits

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission